Gefitinib or Chemotherapy for Non–Small-Cell Lung Cancer with Mutated EGFRMakoto Maemondo, Toshihiro Nukiwa, Akihiko Gemma et al.|New England Journal of Medicine|2010Cited by 5.6k
First-Line Gefitinib for Patients With Advanced Non–Small-Cell Lung Cancer Harboring Epidermal Growth Factor Receptor Mutations Without Indication for ChemotherapyAkira Inoue, Koichi Hagiwara, Kunihiko Kobayashi et al.|Journal of Clinical Oncology|2009Cited by 516
Mutations in the <i>SLC34A2</i> Gene are Associated with Pulmonary Alveolar MicrolithiasisHuqun, Koichi Hagiwara, Shinyu Izumi et al.|American Journal of Respiratory and Critical Care Medicine|2006Cited by 196